T. Warner

发表

This information is current as Inflammatory Responses in Humans Effects of Low-Dose Aspirin on Acute

D. Gilroy, P. Colville-Nash, G. Bellingan, 2009 .

Reduction of platelet thromboxane A2 production ex vivo and in vivo by clopidogrel therapy

J. Mitchell, P. Armstrong, T. Warner, 2010, Journal of thrombosis and haemostasis : JTH.

ISTH Advanced Training Course on platelet bleeding disorders: How should they be investigated?

S. Watson, Andrew Paterson, N. Morgan, 2016, Platelets.

In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation

J. Jakubowski, J. Mitchell, N. Kirkby, 2011, Journal of thrombosis and haemostasis : JTH.

What can we learn from senescent platelets, their transcriptomes and proteomes?

P. Armstrong, Harriet E Allan, T. Warner, 2023, Platelets.

Aspirin has little additional anti-platelet effect in healthy volunteers receiving prasugrel

J. Mitchell, T. Warner, G. Milne, 2011, Journal of thrombosis and haemostasis : JTH.

96-well plate-based aggregometry.

M. Chan, P. Armstrong, T. Warner, 2018, Platelets.

Immature platelet dynamics are associated with clinical outcomes after major trauma

H. Schofield, K. Brohi, P. Armstrong, 2023, medRxiv.

Antiplatelet effects of aspirin vary with level of P2Y12 receptor blockade supplied by either ticagrelor or prasugrel

T. Warner, J. Mitchell, N. Kirkby, 2011, Journal of thrombosis and haemostasis : JTH.

Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay.

S. Mundell, D. Bem, N. Kirkby, 2014, Blood.

265 PLASMA MICRORNAS AS BIOMARKERS FOR PLATELET INHIBITION

M. Mayr, A. Zampetaki, S. Kiechl, 2013, Heart.